Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target

STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma

(2011) A. Scuto et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Expression of heat shock proteins in classical Hodgkin lymphoma: correlation with apoptotic pathways and prognostic significance

(2011) Almudena Santón et al.   HISTOPATHOLOGY

Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death

(2010) R. Zappasodi et al.   CANCER RESEARCH

Hsp105 reduces the protein aggregation and cytotoxicity by expanded-polyglutamine proteins through the induction of Hsp70

(2010) Nobuyuki Yamagishi et al.   EXPERIMENTAL CELL RESEARCH

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

(2010) Corrado Tarella et al.   JOURNAL OF CLINICAL ONCOLOGY

Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line

(2010) Dario Caccia et al.   Molecular Cancer

Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls

(2010) J. E. Bohonowych et al.   Journal of Oncology

Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction

(2009) Ji Luo et al.   CELL

Hsp105β upregulates hsp70 gene expression through signal transducer and activator of transcription-3

(2009) Nobuyuki Yamagishi et al.   FEBS Journal

Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi

(2009) Hye-Sang Park et al.   JOURNAL OF CUTANEOUS PATHOLOGY

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas

(2009) Leandro C Cerchietti et al.   NATURE MEDICINE

Significant overexpression of Hsp110 gene during colorectal cancer progression

(2009) Slaby   ONCOLOGY REPORTS

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study

(2008) M. Di Nicola et al.   BLOOD

Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA)

(2008) Bechr Hamrita et al.   CLINICA CHIMICA ACTA

Nuclear Localization Mechanism of Hsp105  and its Possible Function in Mammalian Cells

(2008) Y. Saito et al.   JOURNAL OF BIOCHEMISTRY

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

(2008) Bruce D. Cheson et al.   NEW ENGLAND JOURNAL OF MEDICINE